NSEGeneral Updates20 Jun 2026 · 20 Jun 2026, 05:57 pm

General Updates

MEDPLUS · MEDPLUS

✦ AI Summary

MedPlus Health Services Limited announced a regulatory update regarding its subsidiary, Optival Health Solutions Private Limited. The subsidiary has received a suspension order for the Drug License of one of its stores. This specific store is located in the state of Telangana. For investors, this indicates a minor operational disruption due to a regulatory action affecting a single retail outlet within the company's wider network.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

General Updates

Attachments (1)

📄

MEDPLUS_20062026175649_Intimation.pdf

pdf

Download →
View document text
MedPlus Health Services Limited June 20, 2026 The Listing Department The Listing Department BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received one suspension order for a Drug License of a store situated in the state of Telangana: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Authority Nature and details Date of receipt Details of the Impact on of the action(s) of direction or violation(s)/ financial taken, initiated or order, including contravention(s) operation or order(s) passed any interim or committed or other activities interim orders, alleged to be of the listed or any other committed entity, communication quantifiable in from the monetary terms authority to the extent possible Assistant Director, Drugs Suspension of Drug Order received Under Rule 65 of Potential Control Administration, License for three on 19.06.2026 Drugs and Revenue Loss of Hyderabad, Telangana. days of store Cosmetics Act, 1940 Rs 0.78 lacs. situated at and Drugs and Vijaynagar Colony, Cosmetics Rules, Telangana. 1945 The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Gangadi Madhukar Reddy Managing Director and Chief Executive Officer DIN: 00098097 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com